Evaluating prognostic utility of preoperative Neutrophil to Lymphocyte Ratio and hsa-let-7g/c up-regulation in patients with urinary bladder cancer-Reference-Cited by-同舟云学术

Evaluating prognostic utility of preoperative Neutrophil to Lymphocyte Ratio and hsa-let-7g/c up-regulation in patients with urinary bladder cancer

Published:2019-12-30 Issue:1 Volume:27 Page:63-73
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Boubaker Nouha Setti¹²,Gurtner Aymone²,Trabelsi Nesrine¹,Manni Isabella²,Said Rahma¹,Ayed Haroun¹³,Ksentini Meriem⁴,Karray Omar³,Saadi Ahmed¹³,Essid Mohamed Ali³,Blel Ahlem⁴,Rammeh Soumaya⁴,Chebil Mohamed³,Piaggio Giulia²,Ouerhani Slah¹

Affiliation:

1. Laboratory of Proteins Engineering and Bioactive Molecules, INSAT, University of Tunis Carthage, Tunis, Tunisia

2. UOSD SAFU, Department of Research, Diagnosis and Innovative Technologies, IRCCS-Regina Elena National Cancer Institute, Rome, Italy

3. Urology Department, Charles Nicolle Hospital, Tunis, Tunisia

4. Pathology Department, Charles Nicolle Hospital, Tunis, Tunisia

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference40 articles.

1. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends;Antoni;Eur Urol,2017

2. V. Soukup, O. Capoun, D. Cohen, V. Hernandez, M. Burger, E. Comperat, P. Gontero, T. Lam, A.H. Mostafid, J. Palou, B.W.G. van Rhijn, M. Roupret, S.F. Shariat, R. Sylvester, Y. Yuan, R. Zigeuner and M. Babjuk, Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Eur Urol Focus (2018).